Abstract
According to the "Fourth universal definition of myocardial infarction," Acute Myocardial Infarction (AMI) is a "myocardial injury detected by abnormal cardiac biomarkers with clinical evidence of acute myocardial ischemia" [1]. The criteria include abnormal cardiac troponin (cTn) values with at least one value above the 99th percentile upper reference limit (URL), and at least one of the following:
Original language | English |
---|---|
Title of host publication | Reducing Mortality in Critically Ill Patients |
Editors | Giovanni Landoni, Martina Baiardo Redaelli, Chiara Sartini, Alberto Zangrillo, Rinaldo Bellomo |
Publisher | Springer International Publishing |
Pages | 115-124 |
Number of pages | 10 |
Edition | 2 |
ISBN (Electronic) | 9783030719173 |
ISBN (Print) | 9783030719166 |
DOIs | |
Publication status | Published - 8 Jun 2021 |
Keywords
- Acute myocardial infarction
- Anti-platelet therapy
- Fibrinolysis
- Myocardial ischemia
- Novel anti-platelet medication
- STEMI, NSTEMI